Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
abbvie
5
×
astrazeneca
5
×
biotech
boston blog main
boston top stories
5
×
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
indiana blog main
indiana top stories
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
5
×
texas top stories
wisconsin blog main
wisconsin top stories
cancer
eli lilly
pfizer
amgen
bristol-myers squibb
celgene
clinical trials
fda
microbiome
startups
alzheimer's disease
What
bio
roundup
5
×
drug
biotech
conference
fda
news
opioid
week
abbvie’s
acquisitions
alzheimer’s
annual
approved
assessed
attention
august
barbecuing
biggest
build
busy
buy
camping
cardiologist
center
ceo
check
cholesterol
communities
companies
company’s
daniel
day
days
debut
decisions
devices
digital
disease
drugs
Language
unset
Current search:
astrazeneca
×
abbvie
×
" texas blog main "
×
" boston top stories "
×
roundup
×
@xconomy.com
3 years ago
Bio Roundup: SeaGen Scores, Dyne’s Debut, Microbiome Moves & More
@xconomy.com
4 years ago
Bio Roundup: Cholesterol Check, J&J’s Opioid Hit, AbbVie’s Flop & More
@xconomy.com
4 years ago
Bio Roundup: Sarepta’s Stumble, Opioid Suits, Shkreli’s Legacy & More
@xconomy.com
5 years ago
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Puzzle, ESMO Assessed, Drug Prices & More